LLY
Eli Lilly and CompanyPharmaceuticals, Biotechnology & Life Sciences
- Rank · 2026
- #302
- Final score
- 57.95
- Years on list
- 7
↘ Down 7 since 2020
Compare · Up to four Russell 1000 companies
Select two, three, or four Russell 1000 companies to compare their overall rank, year-by-year trajectory, and scores down to the category level.
Figure 01 · Side-by-side summary
Pharmaceuticals, Biotechnology & Life Sciences
↘ Down 7 since 2020
Pharmaceuticals, Biotechnology & Life Sciences
↗ Climbed 444 since 2020
Pharmaceuticals, Biotechnology & Life Sciences
↗ Climbed 44 since 2020
Figure 02 · Rank trajectory
Lower is better. The y-axis is inverted so a rising line means an improving rank. Missing years mean the company didn't make the top 100 that year.
Figure 03 · Pillar profile · 2026
Latest-year ESG pillar scores, 0–100. The shaded bar shows relative strength across the selected companies for each pillar.
| Pillar | LLY | ALNY | DHR |
|---|---|---|---|
| Climate Change | 63.9 | 71.1 | 70.2 |
| Employee Relations | 59.4 | 57.3 | 49.4 |
| Environment | 63.1 | 61.1 | 47.6 |
| Stakeholders & Society | 56.4 | 61.0 | 64.7 |
| Human Rights | 36.7 | 30.1 | 56.1 |
| Governance | 53.1 | 48.4 | 51.0 |
| Performance Rating | 66.7 | 65.1 | 62.0 |